Profil
Scott A. Byrd currently works at Outpost Medicine, Inc., as President, CEO, Secretary & Treasurer, Outpost Medicine Ltd., as President & Chief Executive Officer from 2017, Sudo Biosciences, Inc., as Chief Executive Officer & Director from 2021, Acacia Pharma Group Ltd., as Independent Chairman, Acacia Pharma Ltd., as Non-Executive Director, and AlgoTherapeutix SAS, as Independent Director.
Mr. Byrd also formerly worked at Eli Lilly & Co., as Senior Director-Global Brands, Mallinckrodt Hospital Products, Inc., as Chief Commercial Officer & Senior Vice President from 2009 to 2014, and Acacia Pharma, Inc., as President & Chief Operating Officer from 2009 to 2014.
Mr. Byrd received his undergraduate degree from Bradley University and Masters Business Admin degree from Harvard Business School.
Postes actifs de Scott A. Byrd
| Sociétés | Poste | Début |
|---|---|---|
| ACACIA PHARMA GROUP PLC | Président | 02/03/2020 |
Acacia Pharma Ltd.
Acacia Pharma Ltd. Pharmaceuticals: MajorHealth Technology Provides supportive care product opportunities for post-surgical and cancer patients | Directeur/Membre du Conseil | - |
Algotherapeutix SAS
Algotherapeutix SAS Medical SpecialtiesHealth Technology Manufactures clinical supplies | Directeur/Membre du Conseil | - |
Sudo Biosciences, Inc.
Sudo Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that designs and develops medicines that target the tyrosine kinase | Directeur Général | 01/04/2021 |
Anciens postes connus de Scott A. Byrd
| Sociétés | Poste | Fin |
|---|---|---|
Outpost Medicine Ltd.
Outpost Medicine Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur Général | 05/09/2023 |
| CADENCE PHARMACEUTICALS, INC. | Corporate Officer/Principal | 19/03/2014 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Outpost Medicine, Inc.
Outpost Medicine, Inc. Pharmaceuticals: MajorHealth Technology Engages in drug development activities | Directeur Général | - |
Acacia Pharma, Inc.
Acacia Pharma, Inc. Medical DistributorsDistribution Services Distributes pharmaceutical products | President | 01/01/2014 |
Formation de Scott A. Byrd
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Bradley University
Bradley University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mallinckrodt Hospital Products, Inc.
Mallinckrodt Hospital Products, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Acacia Pharma Ltd.
Acacia Pharma Ltd. Pharmaceuticals: MajorHealth Technology Provides supportive care product opportunities for post-surgical and cancer patients | Health Technology |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Acacia Pharma Group Ltd.
Acacia Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company that engages in developing and commercializing novel products for surgery, invasive procedures & chemotherapy | Health Technology |
Acacia Pharma, Inc.
Acacia Pharma, Inc. Medical DistributorsDistribution Services Distributes pharmaceutical products | Distribution Services |
Outpost Medicine, Inc.
Outpost Medicine, Inc. Pharmaceuticals: MajorHealth Technology Engages in drug development activities | Health Technology |
Outpost Medicine Ltd.
Outpost Medicine Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Algotherapeutix SAS
Algotherapeutix SAS Medical SpecialtiesHealth Technology Manufactures clinical supplies | Health Technology |
Sudo Biosciences, Inc.
Sudo Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that designs and develops medicines that target the tyrosine kinase | Health Technology |
















